Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 432
Selected: 0
NCT IDTitle
NCT06160895A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects
NCT07294261Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC
NCT07269145A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors
NCT02734966Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury
NCT06644417Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection
NCT03019276A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics
NCT02449343Study of Anlotinib in Patients With Soft Tissue Sarcoma(STS)(ALTER0203)
NCT04203719A Study of Anlotinib and AK105 Injection in Subjects With Advanced Head, Neck and Chest Cancer
NCT06245941A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)
NCT02809534A Study of Anlotinib in Patients With Hepatocellular Carcinoma
NCT06439381Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps
NCT04144855A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3474 Injection
NCT06150014A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B
NCT05894421TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers
NCT06542614Treatment of Moderate to Severe Plaque Psoriasis
NCT04213118Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence
NCT04822805A Study of Anlotinib in the Treatment of Recurrent High-grade Glioma
NCT06931145Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer
NCT03456466Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma
NCT04808570A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT06706310Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection
NCT04325776A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis
NCT06767813Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms
NCT07293390A Clinical Trial of Mass Balance of [14C] TQ05105 in Healthy Chinese Subjects
NCT06552520To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis
NCT05013697TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.
NCT04569838A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection
NCT05333276Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced Cancers
NCT04854668A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer
NCT03099330A Phase I Study of TQ-B3139 on Tolerance and Pharmacokinetics
NCT04956328Study of Obeticholic Acid(OCA) Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)
NCT06413953A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors
NCT04385563A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.
NCT06500091TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors
NCT07008976Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer
NCT03996408Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma
NCT05780567Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer
NCT06649656A Multicenter, Open Label Phase I Clinical Trial Evaluating the Safety and Pharmacokinetics of TQB2252 Injection in Subjects With Advanced Malignant Tumors
NCT02649361Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)
NCT03972189Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC)
NCT04675060Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 Capsules
NCT04944043A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease
NCT06116240A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors
NCT07113925A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies
NCT05121363A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma
NCT04975204A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors
NCT04853498A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets
NCT07400406A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries
NCT05975645A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC).
NCT07267130A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects